Positive context积极背景
Stocks股票 / Health Care / SRPT
Sarepta Therapeutics · Health Care
SRPT US listed · USD美股 · 美元
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States.Sarepta Therapeutics, Inc. 是一家医疗研究与药物开发公司，其公司办公室和研究设施位于美国马萨诸塞州剑桥市。
Small cap小盘 · $2B
Health Care
S&P 600标普600小盘Russell 2000罗素2000
Speculative / unprofitable投机／未盈利
$18.42
+$0.04 · +0.22%
52w low52周低 $14.46high高 $25.09
Neutral — no clear edge中性 — 无明显优势
The daily turn is already in — a low formed ~9 days ago at $14.86 and price is back above the 10-day average. What's missing is the weekly timeframe…日线转向已经完成——低点于约 9 天前形成，价位14.86，且价格已重新站上 10 日均线。尚缺的是周线周期的确认，因此这是当下可用的部分信心入场，而非待触发信号：可在此建半仓，或等待周线转向。
Live实时
Company intelligence公司情报
The latest call, in context把最新财报放回历史脉络
A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考；使用前请在电话会原文中核对准确措辞。
Live company record实时公司记录
JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动，请打开终端。
Continue with full transcript history继续查看完整电话会历史 ↗Pressure context压力背景
History mode历史模式
Context only仅供参考 · not a signal or recommendation不构成信号或建议
Narrative claims may await line-level citation; verify in the transcript.叙述性内容可能仍待逐行引用，请在电话会原文中核对。
Price chart价格图表
daily · interactive日线 · 可交互
Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。
Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。
MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗
Technicals技术面
daily bars日线数据 · 2026-08-14
Momentum (RSI 14)动量（RSI 14）
63
Elevated偏高
vs 50-day average相对50日均线
+8.7% above上方
Uptrend intact趋势完好
vs 200-day average相对200日均线
-3.9% below下方
Long trend down长期向下
Volatility波动率
12th percentile第12百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源，每晚更新。
Earnings财务业绩
Estimates being cut预期下调
Valuation估值
Looks cheap vs sector相对行业偏便宜| Multiple指标 | SRPT | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/B市净率 | 1.70x | 3.54 | |
| P/S市销率 | 0.88x | 3.20 | |
| Earnings yield盈利收益率 | -36.90% | 2.51 | |
| FCF yield自由现金流收益率 | -15.90% | 4.00 | |
| Shareholder yield股东收益率 | 1.29% | 1.83 |
"Cheaper than" = share of sector peers trading richer on that multiple.「相对便宜」= 行业中该指标估值更高的同行占比。
Financials财务数据
fiscal years财年Revenue营业收入
$2.2B2025
20202025
5-yr growth5年复合增速 32.4%
Earnings per share每股收益
$-7.132025
20202025
Free cash flow自由现金流
-$307.5M2025
20202025
Operating margin营业利润率
-31.8%
Net margin净利率
-32.5%
FCF margin自由现金流利润率
-9.3%
Balance-sheet quality财务体质 3/8
Bankruptcy risk: distress zone破产风险：警戒区
Return on equity股本回报率 -62%
Warning警示
Leverage杠杆
Current ratio流动比率2.32
Capital allocation资本配置
Stock-based comp股权薪酬$123.4M
Share count change (1y)股数变化（1年）+8.3%
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
SRPT daily MACD crossed upSRPT 日线MACD上穿
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向： -$0.1M net (0 buyers, 1 sellers)-$0.1M 净值（0 买家，1 卖家）
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | As of截至 |
|---|---|---|---|---|
| RA Capital Management | D | New position新建仓 | 0.9% | 2026-03-31 |
Signal history信号历史
engine events引擎事件
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP. A new cycle low likely formed 9 day(s) ago (2026-07-31 @ 14.86): swing low in, price back above the 10-day average — but the weekly timeframe hasn't turned yet, so conviction is partial. Last cycle was left-translated (topped early) — a bearish structural tell买入预备。新的周期低点可能已在 9 天前形成 （2026-07-31 @ 14.86）：摆动低点已现，价格重新站上 10 日均线——但周线周期尚未转向，因此信心仅为部分。 上一周期为左移结构（见顶偏早）——属于看空的结构性信号
Aug 6, 2026
SRPT daily MACD crossed upSRPT 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $16.78.日线MACD柱状图转正 — 快速且嘈杂，仅作背景。$16.78。
Aug 5, 2026
SRPT broke down vs the marketSRPT 相对市场走弱
Relative strength vs SPY crossed below the 10th percentile of the last 90 days — weakness often leads price. $15.93.相对标普500的强弱下穿近90日的第10百分位 — 走弱常先于价格。$15.93。
Aug 3, 2026
SRPT StochRSI turned up from oversoldSRPT StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $15.88.StochRSI重回20上方 — 下行动量趋缓的最早预警。$15.88。
Jul 31, 2026
UNCONFIRMED TURN → DOWNTREND未确认转向 → 下跌趋势
AVOID回避
Jul 31, 2026
SRPT made a new 52-week lowSRPT 创52周新低
Price reached a fresh 52-week low — a momentum / trend extreme the whole market watches. $14.86.价格创出52周新低 — 全市场关注的动量/趋势极值。$14.86。
Jul 30, 2026
SRPT broke down vs the marketSRPT 相对市场走弱
Relative strength vs SPY crossed below the 10th percentile of the last 90 days — weakness often leads price. $15.56.相对标普500的强弱下穿近90日的第10百分位 — 走弱常先于价格。$15.56。
Jul 29, 2026
NEARING A LOW → UNCONFIRMED TURN接近低点 → 未确认转向
HIGH-RISK · NIMBLE ONLY高风险 · 仅限灵活操作
Jul 28, 2026
UNCONFIRMED TURN → NEARING A LOW未确认转向 → 接近低点
GET READY准备
Jul 28, 2026
SRPT broke down vs the marketSRPT 相对市场走弱
Relative strength vs SPY crossed below the 10th percentile of the last 90 days — weakness often leads price. $15.43.相对标普500的强弱下穿近90日的第10百分位 — 走弱常先于价格。$15.43。
Showing the last 15 of显示最近15条，共 256 signals条信号
Company profile公司档案
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States.Sarepta Therapeutics, Inc. 是一家医疗研究与药物开发公司，其公司办公室和研究设施位于美国马萨诸塞州剑桥市。
Style DNA — how it trades vs the market风格基因 — 相对市场的交易特征
Value价值
Below market低于市场
Quality质量
Above market高于市场
Investment资本投入
Above market高于市场
Shareholder payout股东回报
Below market低于市场
Low volatility低波动
Below market低于市场
Low market beta低市场敏感度
Below market低于市场
Earnings quality盈利质量
Below market低于市场
Short interest空头兴趣
Above market高于市场
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Statistics — full detail统计数据 — 完整明细
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| Price / Book市净率 | 1.7× | 3.5× | 85% |
| Price / Sales市销率 | 0.9× | 3.2× | 83% |
| Earnings yield盈利收益率 | -36.9% | 2.5% | 4% |
| Free-cash-flow yield自由现金流收益率 | -10.6% | 5.3% | 2% |
| Shareholder yield股东综合回报率 | 1.3% | 1.8% | 37% |
Relative strength相对强度
vs market, 1 month相对大盘（1个月）
70/100 — stronger than most强于多数
vs market, 3 months相对大盘（3个月）
29/100 — weaker than most弱于多数
vs market, 6 months相对大盘（6个月）
60/100 — middle of the pack居中
vs market, 12 months相对大盘（12个月）
59/100 — middle of the pack居中
Rank in sector行业内排名
#93 / 172
0–100 percentile of total return vs all covered stocks.总回报在全部覆盖股票中的百分位（0–100）。
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | +9.8% | +1.2% |
| 1 Month近1月 | +2.6% | +3.5% |
| 3 Months近3月 | +5.0% | +5.2% |
| 6 Months近6月 | +3.5% | +14.4% |
| Year to date年初至今 | -13.6% | +14.2% |
| 1 Year近1年 | -9.7% | +21.6% |
| 3 Years近3年 | -83.6% | +79.7% |
Trading information交易信息
Beta vs market贝塔
2.04
Volatility rank波动率分位
12th pctile
Short interest空头占比
26.3% of float
Market cap市值
$2B
EPS (trailing)每股收益
$-6.80
Off 52-week high距52周高点
-24.7%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Financials — full detail财务数据 — 完整明细
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $540M | $702M | $933M | $1.2B | $1.9B | $2.2B |
| EPS每股收益 | $-7.11 | $-5.15 | $-8.03 | $-5.80 | $2.34 | $-7.13 |
| Free cash flow自由现金流 | $25M | $-482M | $-356M | $-577M | $-343M | $-307M |
| Gross margin毛利率 | — | — | — | — | — | 98.8% |
| Net margin净利率 | -102.6% | -59.7% | -75.4% | -43.1% | 12.4% | -32.5% |
| FCF margin自由现金流利润率 | 4.7% | -68.6% | -38.2% | -46.4% | -18.0% | -14.0% |
Latest fiscal year最近财年
Revenue (FY)营业收入（财年）
$2.2B
Net income净利润
$-713M
Operating cash flow经营现金流
$-205M
Total assets总资产
$3.3B
Shareholder equity股东权益
$1.1B
Buybacks股票回购
$25M
Shares outstanding总股本
0.10B
Returns & growth回报与增长
Return on equity股本回报率
-62.5%
Return on assets资产回报率
-21.3%
Profit growth利润增速
-403.3%
Asset growth资产增速
-15.5%
Accounting quality checks会计质量检查
- Earnings quality: accruals trending up over 6 fiscal years — earnings increasingly not cash-backed盈利质量：应计利润在 6 个财年间走高——盈利的现金支撑减弱
- Working capital: working capital roughly in line with sales营运资本：营运资本与销售大致同步
- Capital discipline: share count +32.2% over 6 years (dilution)资本纪律：股本 6 年增加 32.2%（稀释）
- Balance sheet: Altman Z -1.03 — distress zone资产负债表：Altman Z -1.03——困境区
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Technicals — full detail技术面 — 完整明细
Indicator readings指标读数
RSI (14-day)RSI（14日）
63
RSI (2-day)RSI（2日）
98
vs 20-day average相对20日均线
+12.0%
vs 50-day average相对50日均线
+8.7%
vs 200-day average相对200日均线
-3.9%
Golden cross (50>200)金叉（50>200）
not in effect未生效
MACDMACD
above signal位于信号线上方
Timeframe alignment多周期共振
Daily日线
momentum up动能向上
3-day3日线
momentum up — fresh upturn动能向上——刚刚转强
Weekly周线
momentum up动能向上
When daily through monthly point the same way, moves carry further.当日线到月线方向一致时，行情往往更有延续性。
Volatility regime波动状态
Range width percentile波幅宽度分位
42/100
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Earnings — full detail财务业绩 — 完整明细
Estimate revisions预期修正
Analysts covering覆盖分析师
12
Estimate direction预期调整方向
mostly cutting多数下调
Estimate change, 90 days预期变化（90天）
-18.5%
Net upgrades, 30 days净上调（30天）
-2
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Ownership — full detail持仓 — 完整明细
Tracked funds holding it跟踪基金持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | Position市值 |
|---|---|---|---|---|
| RA Capital Management | D | New position新建仓 | 0.9% | $85M |
Fund positioning基金持仓概览
Tracked funds in the name持有该股的跟踪基金
1
Buying vs selling买入vs卖出
1 : 0
Quarterly trend季度趋势
{'direction': 'distributing', 'n_quarters': 11, 'holders_first': 2, 'holders_last': 1, 'holders_delta': -1, 'value_change_pct': -42.5, 'from_period': '2023-09-30', 'to_period': '2026-03-31', 'available_on': '2026-05-16', 'available_on_first': '2023-11-15', 'holders_series': [2, 2, 3, 1, 2, 2, 1, 1, 0, 0, 1]}{'direction': 'distributing', 'n_quarters': 11, 'holders_first': 2, 'holders_last': 1, 'holders_delta': -1, 'value_change_pct': -42.5, 'from_period': '2023-09-30', 'to_period': '2026-03-31', 'available_on': '2026-05-16', 'available_on_first': '2023-11-15', 'holders_series': [2, 2, 3, 1, 2, 2, 1, 1, 0, 0, 1]}
Insiders & shorts内部人与空头
Insider net buying (6 months)内部人净买入（6个月）
-$0.1M
Insider buyers vs sellers内部人买家vs卖家
0 : 1
Short interest空头占流通盘
26.3%
Days to cover回补天数
8.8
Short interest change空头变化
-3.2%
Recent fund flows近期基金流向
SPDR S&P BiotechSPDR S&P Biotech
accumulating持续增持
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Seasonality — full detail季节性 — 完整明细
Strongest month最强月份
Aug · 75%
Weakest month最弱月份
Jul · 25%
Month by month逐月统计
| Month月份 | Closed higher收涨占比 | Median move中位涨跌 | Years年数 |
|---|---|---|---|
| Jan1月 | 33% | -3.6% | 3 |
| Feb2月 | 33% | -5.8% | 3 |
| Mar3月 | 67% | +1.4% | 3 |
| Apr4月 | 33% | -1.8% | 3 |
| May5月 | 33% | -14.2% | 3 |
| Jun6月 | 67% | +2.1% | 3 |
| Jul7月 | 25% | -0.9% | 4 |
| Aug8月 | 75% | +12.8% | 4 |
| Sep9月 | 67% | +0.5% | 3 |
| Oct10月 | 67% | +1.2% | 3 |
| Nov11月 | 67% | +7.4% | 3 |
| Dec12月 | 67% | +2.0% | 3 |
History is a tendency, not a promise — small samples wobble.历史规律只是倾向而非保证 — 样本少时波动大。
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。